Evidence map›Paper›PMID 42416769›Full record

ReviewMaedica2026

Immunological Considerations and Biological Consequences of Intradiscal Needle Procedures: Implications for Chemo-Nucleolysis and Oxygen-Ozone Therapy.

Aniello Langella, Marianno Franzini, Luigi Valdenassi, Francesco Vaiano, Umberto Tirelli, Salvatore Chirumbolo

Abstract readReview
In one paragraph

Review in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aniello LangellaItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Bergamo, Italy.
Marianno FranziniItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Bergamo, Italy.
Luigi ValdenassiItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Bergamo, Italy.
Francesco VaianoItalian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Bergamo, Italy.
Umberto TirelliTirelli Medical Group, Pordenone, Italy.
Salvatore ChirumboloDepartment of Engineering for Innovation Medicine, University of Verona, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intervertebral disc (IVD) procedures, including chemo-nucleolysis and oxygen-ozone therapy (OOT), are increasingly used as minimally invasive approaches for disc herniation and radiculopathy. Although generally considered safe, these interventions may induce biological and immunological consequences that remain insufficiently characterized. This editorial discusses the immunobiology of the nucleus pulposus (NP) and the potential effects of annular disruption caused by intradiscal needle procedures. Under physiological conditions, the NP behaves as a relatively immune-privileged tissue because of its avascular structure, extracellular matrix composition, and local immunomodulatory mechanisms. Mechanical disruption of the annulus fibrosus may expose NP-derived antigens and damage-associated molecular patterns (DAMPs) to immune surveillance, activating inflammatory pathways involving Toll-like receptors, NF-κB signalling, inflammasomes, cytokine release, oxidative stress, and extracellular matrix degradation. Although chemo-nucleolysis and OOT may reduce intradiscal pressure and alleviate symptoms, current evidence does not demonstrate restoration of annular integrity or complete recovery of disc immune privilege. A deeper understanding of IVD immunobiology may improve patient selection, procedural safety and long-term therapeutic strategies in minimally invasive spine care.

Indexed as

chemo-nucleolysisdisc degenerationimmune privilegeintervertebral discoxygen–ozone therapy

Identifiers

PMID42416769
PMCPMC13325760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.